Insider Trading Alert - MMI, LMAT And SPG Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, May 11, 2015, 93 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $1,570.00 to $275,612,220.00.

Highlighted Stocks Traded by Insiders:

Marcus & Millichap (MMI) - FREE Research Report

Louie Martin E., who is Chief Financial Officer at Marcus & Millichap, sold 14,453 shares at $40.00 on May 11, 2015. Following this transaction, the Chief Financial Officer owned 58,986 shares meaning that the stake was reduced by 19.68% with the 14,453-share transaction.

The shares most recently traded at $40.73, up $0.73, or 1.79% since the insider transaction. Historical insider transactions for Marcus & Millichap go as follows:

  • 4-Week # shares sold: 600,000
  • 12-Week # shares sold: 3.8 million
  • 24-Week # shares sold: 4.3 million

The average volume for Marcus & Millichap has been 228,400 shares per day over the past 30 days. Marcus & Millichap has a market cap of $1.6 billion and is part of the financial sector and real estate industry. Shares are up 28.24% year-to-date as of the close of trading on Monday.

Marcus & Millichap, Inc., a brokerage company, provides investment brokerage and financing services to sellers and buyers of various types and sizes of commercial real estate assets in the United States and Canada. The company has a P/E ratio of 33.6. Currently, there is 1 analyst who rates Marcus & Millichap a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MMI - FREE

TheStreet Quant Ratings rates Marcus & Millichap as a hold. The company's strengths can be seen in multiple areas, such as its notable return on equity, robust revenue growth and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we find that the company's profit margins have been poor overall. Get the full Marcus & Millichap Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

LeMaitre Vascular (LMAT) - FREE Research Report

Roberts David B, who is President and Director at LeMaitre Vascular, sold 15,000 shares at $10.31 on May 11, 2015. Following this transaction, the President and Director owned 249,839 shares meaning that the stake was reduced by 5.66% with the 15,000-share transaction.

The shares most recently traded at $9.99, down $0.32, or 3.17% since the insider transaction. Historical insider transactions for LeMaitre Vascular go as follows:

  • 4-Week # shares sold: 81,984
  • 12-Week # shares sold: 100,049
  • 24-Week # shares sold: 196,914

The average volume for LeMaitre Vascular has been 39,400 shares per day over the past 30 days. LeMaitre Vascular has a market cap of $179.7 million and is part of the health care sector and health services industry. Shares are up 33.86% year-to-date as of the close of trading on Monday.

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants for the treatment of peripheral vascular disease worldwide. The stock currently has a dividend yield of 1.56%. The company has a P/E ratio of 42.7. Currently, there are 5 analysts who rate LeMaitre Vascular a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LMAT - FREE

TheStreet Quant Ratings rates LeMaitre Vascular as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full LeMaitre Vascular Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Simon Property Group (SPG) - FREE Research Report

Hubbard Allan B, who is Director at Simon Property Group, bought 183 shares at $187.57 on May 11, 2015. Following this transaction, the Director owned 10,299 shares meaning that the stake was boosted by 1.81% with the 183-share transaction.

The shares most recently traded at $183.79, down $3.78, or 2.06% since the insider transaction. Historical insider transactions for Simon Property Group go as follows:

  • 4-Week # shares bought: 134
  • 4-Week # shares sold: 5,400
  • 12-Week # shares bought: 134
  • 12-Week # shares sold: 5,400
  • 24-Week # shares bought: 134
  • 24-Week # shares sold: 27,269

The average volume for Simon Property Group has been 1.5 million shares per day over the past 30 days. Simon Property Group has a market cap of $58.4 billion and is part of the financial sector and real estate industry. Shares are up 3.04% year-to-date as of the close of trading on Monday.

Simon Property Group, Inc. is an equity real estate investment trust. The firm invests in the real estate markets across the globe. It engages in investment, ownership, management, and development of properties. The stock currently has a dividend yield of 2.93%. The company has a P/E ratio of 40.7. Currently, there are 15 analysts who rate Simon Property Group a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on SPG - FREE

TheStreet Quant Ratings rates Simon Property Group as a buy. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year, impressive record of earnings per share growth, increase in net income, revenue growth and notable return on equity. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Simon Property Group Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Asia Markets Fall on Latest Tariff Threats From Trump

Asia Markets Fall on Latest Tariff Threats From Trump

Google Invests in JD.com; Comcast-Disney Battle Nears Head -- ICYMI

Google Invests in JD.com; Comcast-Disney Battle Nears Head -- ICYMI

REPLAY: Jim Cramer on Tariff Worries, Oil, Alphabet and Centene

REPLAY: Jim Cramer on Tariff Worries, Oil, Alphabet and Centene

Video: Athens Stock Exchange CEO on What's Next for Greece's Debt Woes

Video: Athens Stock Exchange CEO on What's Next for Greece's Debt Woes

Dow Drops Over 100 Points on Trade War Worries

Dow Drops Over 100 Points on Trade War Worries